Bioproduction Congress 2024
Tours, France
Quality Assistance will attend
the Bioproduction Congress 2024
The Bioproduction Congress is the annual event of the biopharmaceutical production sector. This event will bring together experts from companies and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.
MEET US THERE
Rémy Delmotte, Key Account Manager, and Julie Jia, Business Developer, will attend the conference. Make sure to exchange with them on the latest bioproduction trends and on your analytical needs at table 28.
SCIENTIFIC PRESENCE
Arnaud Delobel, R&D and Innovation Director, will present on "Multi-Attribute Analysis of mRNA by LC/MS" during the "Analytical Methods" session.
Gery Van Vyncht, Scientific Director, will present on "GIC A3P Biotherapy Processes - Update on Technical Guide : How to optimize the development and industrialization of your Biotherapy Product" with Marie Cecille, Head of CMC Leader from Merck Life Science.
PARTNER WITH A LEADING ANALYTICAL CRO
With more than 40 years’ experience, Quality Assistance has become a leader in analytical sciences and holds a unique position on the market with all its laboratories on one site and 250 highly qualified professionals. Quality Assistance centralises all analytical services on one site:
- Analytical development
- Stability studies
- Batch testing
- Statistical services
- Bioanalytical services
- Elemental impurities
- Characterisation of proteins by MS
PRODUCT-DEDICATED EXPERTISE
Monoclonal antibodies
Take no risk with your analytics when developing new therapeutic monoclonal antibodies. Our analytical teams take advantage of their extensive experience with the analysis of mAbs. Throughout non-clinical and clinical development, our experts provide you with the customised solutions in terms of analytical protocols and innovative technologies to help you move your product from discovery to the market place.
Vaccines
Whatever the type of antigen, Quality Assistance covers a wide range of analytical technologies needed to support vaccine development, including product characterisation, development and validation of analytical methods, stability studies, batch testing and bioanalysis to support immunogenicity and protection studies.
CBMPs
Quality Assistance offers extensive experience with analytical development and validation and GMP/GLP compliant laboratories to assist in the development of your cell-based medicinal products.
Viral vectors
Due to their complex structure and size, as well as a constantly evolving regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is challenging.
Building on our considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your products. We continuously invest in new technologies and machinery and are able to assist you in the development of your recombinant Adeno-Associated Viral Vectors products from early phases to marketing authorisation.
Register now to the event
More information on http://www.biopcongress.com/